Galt Pharms patent expiration

1. Doral patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7608616 GALT PHARMS Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
Jun, 2028

(3 years from now)




Drugs and Companies using QUAZEPAM ingredient

Market Authorisation Date: 27 December, 1985

Treatment: Method for treating insomnia while reducing the risk of an adverse drug interaction

Dosage: TABLET

More Information on Dosage

DORAL family patents

Family Patents

2. Oravig patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6916485 GALT PHARMS Prolonged release bioadhesive therapeutic systems
Sep, 2022

(1 year, 10 months ago)

US8518442 GALT PHARMS Prolonged release bioadhesive therapeutic systems
Sep, 2022

(1 year, 10 months ago)

US7651698 GALT PHARMS Prolonged release bioadhesive therapeutic systems
Sep, 2022

(1 year, 10 months ago)




Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Apr 16, 2013

Drugs and Companies using MICONAZOLE ingredient

Market Authorisation Date: 16 April, 2010

Treatment: Treatment of oropharyngeal candidiasis

Dosage: TABLET

More Information on Dosage

ORAVIG family patents

Family Patents